Evidence map›Paper›PMID 28225335›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2017

Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs.

L M Cranmer, A Langat, K Ronen, C J McGrath, S LaCourse, J Pintye, B Odeny, B Singa, A Katana, L Nganga and 2 more

Open access · greenAbstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

L M CranmerEmory University School of Medicine and Children's Hospital of Atlanta, Atlanta, Georgia, USA.
A LangatCenters for Disease Control and Prevention, Nairobi, Kenya.
K RonenUniversity of Washington, Seattle, Washington.
C J McGrathUniversity of Texas Medical Branch, Galveston, Texas, USA.
S LaCourseUniversity of Washington, Seattle, Washington.
J PintyeUniversity of Washington, Seattle, Washington.
B OdenyUniversity of Washington, Seattle, Washington.
B SingaKenya Medical Research Institute, Nairobi.
A KatanaCenters for Disease Control and Prevention, Nairobi, Kenya.
L NgangaCenters for Disease Control and Prevention, Nairobi, Kenya.
J KinuthiaKenyatta National Hospital, Nairobi, Kenya.
G John-StewartUniversity of Washington, Seattle, Washington.
University of Washington · USCenters for Disease Control and Prevention · KEEmory University · USKenya Medical Research Institute · KEKenyatta National Hospital · KEThe University of Texas Medical Branch at Galveston · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
PS09-991, KENYA, COPTIC HOSPITAL/UNIVERSITY OF WASHINGTON COLLABORATIVE HIV-1 CARE PROGRAMU2GPS002047 · PS · COPTIC ORTHODOX CHURCH · PI YOWAKIM, PAUL · 2010 to 2016
$27.7M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Interdisciplinary Tranining in Cancer ResearchT32CA080416 · NCI · UNIVERSITY OF WASHINGTON · PI STODDARD, BARRY L. · 1998 to 2023
$9.7M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
Impact of maternal HIV on Mycobacterium tuberculosis infection among peripartum women and their infantsK23AI120793 · NIAID · UNIVERSITY OF WASHINGTON · PI LACOURSE, SYLVIA · 2016 to 2020
$910k
NCHHSTP CDC HHS U2G PS002047NCI NIH HHS T32 CA080416NIAID NIH HHS K23 AI120793NIAID NIH HHS T32 AI007140NICHD NIH HHS K12 HD000850NICHD NIH HHS K24 HD054314PEPFAR
6 · The paper itself

Abstract

backgroundTuberculosis (TB) screening in Prevention of Mother-To-Child Transmission (PMTCT) programs is important to improve TB detection, prevention and treatment.

methodsAs part of a national PMTCT program evaluation, mother-infant pairs attending 6-week and 9-month immunization visits were enrolled at 141 maternal and child health clinics throughout Kenya. Clinics were selected using population-proportion-to-size sampling with oversampling in a high human immunodeficiency virus (HIV) prevalence region. The World Health Organization (WHO) TB symptom screen was administered to HIV-infected mothers, and associations with infant cofactors were determined.

resultsAmong 498 HIV-infected mothers, 165 (33%) had a positive TB symptom screen. Positive maternal TB symptom screen was associated with prior TB (P = 0.04). Women with a positive TB symptom screen were more likely to have an infant with HIV infection (P = 0.02) and non-specific TB symptoms, including cough (P = 0.003), fever (P = 0.05), and difficulty breathing (P = 0.01). TB exposure was reported by 11% of the women, and 15% of the TB-exposed women received isoniazid preventive therapy.

conclusionsPostpartum HIV-infected mothers frequently had a positive TB symptom screen. Mothers with a positive TB symptom screen were more likely to have infants with HIV or non-specific TB symptoms. Integration of maternal TB screening and prevention into PMTCT programs may improve maternal and infant outcomes.

Indexed as

AdultAntitubercular AgentsFemaleHIV InfectionsHumansInfantInfectious Disease Transmission, VerticalIsoniazidKenyaMaleMass ScreeningPostpartum PeriodPregnancyPregnancy Complications, InfectiousPrevalenceTuberculosisAntitubercular AgentsIsoniazid

Identifiers

PMID28225335
PMCPMC5729039
OpenAlexW2586150424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.